Last edition
News about "reference listed drug "
Alembic Pharmaceuticals Gains USFDA Approval for Dapagliflozin Tablets ANDA
Alembic Pharmaceuticals receives USFDA approval for Dapagliflozin Tablets ANDA, gaining eligibility for 180-day shared generic drug exclusivity and strengthening its diabetes portfolio.
Reference Listed Drug | 07/04/2026 | By News Bureau
Alembic Pharmaceuticals Secures US FDA Approval for Paroxetine ER Tablets
U.S. Food and Drug Administration grants final approval to Alembic’s sANDA for paroxetine extended-release tablets, used in treating depression and anxiety-related disorders.
Reference Listed Drug | 30/03/2026 | By News Bureau
ANI Pharmaceuticals Introduces Prucalopride Tablets after FDA Approval
ANI’s Prucalopride Tablets is the generic version of the reference listed drug (RLD) Motegrity.
Reference Listed Drug | 03/01/2025 | By Aishwarya | 578
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy